"Cough, Cold and Allergy (Hay Fever) Remedies in Japan" is now available at Fast Market Research

Current value sales of cough, cold and allergy (hay fever) remedies in Japan grew by 1% to reach a retail sales value of ¥246.4 billion in 2015. The category has a characteristic that is affected by the spread of colds and the level of pollen allergies each year. In 2015 pollen dispersion volume was relatively higher than usual, and the colds started to spread relatively earlier. Thanks to those external factors, sales recovered in many product categories.

Competitive Landscape

Taisho Pharmaceutical remained the top player in cough, cold and allergy (hay fever) remedies in 2015, accounting for a retail value share of 18%. Daiichi Sankyo Healthcare and Takeda Pharmaceutical followed Taisho, accounting for 9% and 7% retail value shares, respectively. The top five players together accounted for 45% of value sales, and the top three ranking players maintained the same position since the start of the review period. Similarly to many other categories of systemic OTCs, domestic manufacturers have enormous presence, holding long-running brands that have been used with high reliability from generation to generation. Pabron from Taisho Pharmaceutical, Benza from Takeda Pharmaceutical and Lulu from Daiichi Sankyo Healthcare remain the top three brands in the overall cough, cold and allergy (hay fever), all of them are combination products - cough, cold and allergy (hay fever) remedies. As an OTC manufacturer in the category, GlaxoSmithKline was the only international manufacturer; it ranked seventh in overall cough, cold and allergy (hay fever) remedies with a retail value share of 4% in 2015. GlaxoSmithKline holds a popular brand of combination products - cough, cold and allergy (hay fever) remedies, Contac, which appeals due to the persistency of its effect with a unique formation of capsule in capsule. As consumer lifestyles have changed and consumers are becoming busier, they are demanding those cough, cold and allergy (hay fever) remedies which last for long hours and require less frequent medication.

Full Report Details at
- http://www.fastmr.com/prod/1082128_cough_cold_allergy_hay_fever.aspx?afid=302

Industry Prospects

Cough, cold and allergy remedies is expected to see a static value performance at constant 2015 prices over the forecast period. Colds and hay fever, which are strongly linked to the sales volume of cough, cold and allergy (hay fever) remedies, are both seasonal ailments that spread at different levels each year. The performance estimate is subjective to some extent due to these unpredictable factors.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Japan with research from Euromonitor's team of in-country analysts.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Cough, Cold and Allergy (Hay Fever) Remedies in the United Arab Emirates
- Cough, Cold and Allergy (Hay Fever) Remedies in Poland
- Cough, Cold and Allergy (Hay Fever) Remedies in Finland
- Cough, Cold and Allergy (Hay Fever) Remedies in Thailand
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea